Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CALL
Corpay
CPAY
$27.4B
| $7.71M | ﹤0.01% |
30,200
-4,600
| -13% | -$1.2M |
|
2952
Sprott Physical Gold
PHYS
$15.8B
| $7.71M | ﹤0.01% |
+538,355
| New | +$8.08M |
|
2953
PUT
Northern Trust
NTRS
$35B
| $7.7M | ﹤0.01% |
110,800
+67,300
| +155% | +$5.08M |
|
2954
MillerKnoll
MLKN
$1.62B
| $7.69M | ﹤0.01% |
314,557
-205,676
| -40% | -$3.85M |
|
2955
Rambus
RMBS
$10.9B
| $7.69M | ﹤0.01% |
137,751
+126,506
| +1,125% | +$7.18M |
|
|
BRY
2956
DELISTED
Berry Corp
BRY
| $7.68M | ﹤0.01% |
936,670
+535,666
| +134% | +$4.29M |
|
2957
iShares MSCI France ETF
EWQ
$332M
| $7.68M | ﹤0.01% |
215,770
-180,228
| -46% | -$6.78M |
|
2958
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $7.68M | ﹤0.01% |
78,600
+3,800
| +5% | +$382K |
|
|
NVMI
2959
Nova
NVMI
$13.3B
| $7.66M | ﹤0.01% |
68,158
-82,302
| -55% | -$9.68M |
|
2960
PUT
Chord Energy
CHRD
$7.51B
| $7.65M | ﹤0.01% |
47,200
+14,000
| +42% | +$2.2M |
|
2961
8x8 Inc
EGHT
$300M
| $7.64M | ﹤0.01% |
3,033,383
+582,387
| +24% | +$2.07M |
|
2962
MannKind Corp
MNKD
$1.24B
| $7.63M | ﹤0.01% |
1,848,258
+448,829
| +32% | +$2.02M |
|
2963
NMI Holdings
NMIH
$3.44B
| $7.63M | ﹤0.01% |
281,591
+165,997
| +144% | +$4.62M |
|
2964
CALL
ARK Genomic Revolution ETF
ARKG
$1.74B
| $7.62M | ﹤0.01% |
273,600
+120,400
| +79% | +$3.94M |
|
2965
CALL
Coty
COTY
$2.51B
| $7.62M | ﹤0.01% |
694,400
+269,800
| +64% | +$3.18M |
|
2966
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $7.62M | ﹤0.01% |
67,700
+39,700
| +142% | +$4.18M |
|
2967
PUT
Huntsman Corp
HUN
$1.81B
| $7.62M | ﹤0.01% |
312,100
+155,600
| +99% | +$4.22M |
|
2968
PUT
Target Hospitality
TH
$1.74B
| $7.61M | ﹤0.01% |
479,200
+138,000
| +40% | +$1.95M |
|
2969
CALL
Commercial Metals
CMC
$7.92B
| $7.6M | ﹤0.01% |
153,900
-31,500
| -17% | -$1.71M |
|
2970
CALL
Leonardo DRS
DRS
$12.2B
| $7.6M | ﹤0.01% |
455,100
-115,500
| -20% | -$1.95M |
|
|
IRBT
2971
DELISTED
iRobot
IRBT
| $7.6M | ﹤0.01% |
200,479
+95,493
| +91% | +$3.83M |
|
2972
Direxion Daily TSLA Bull 2X ETF
TSLL
$3.54B
| $7.59M | ﹤0.01% |
490,737
+345,694
| +238% | +$5.72M |
|
2973
DTE Energy
DTE
$29.3B
| $7.59M | ﹤0.01% |
76,452
+43,275
| +130% | +$4.66M |
|
2974
CALL
StoneCo
STNE
$2.32B
| $7.59M | ﹤0.01% |
711,100
-180,200
| -20% | -$2.22M |
|
2975
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $7.58M | ﹤0.01% |
173,304
+54,700
| +46% | +$2.5M |
|
Similar funds
Citadel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
- Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.